Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation

被引：6
|
作者：
Kovacs, Norbert [1 ]
Janszky, Jozsef [1 ]
Nagy, Ferenc [1 ,2 ]
机构：
[1] Univ Pecs, Dept Neurol, Pecs, Hungary
[2] Kaposi Mor Cty Hosp, Dept Neurol, Kaposvar, Hungary
来源：
DRUGS & AGING | 2011年 / 28卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIAL; INITIAL TREATMENT; LEVODOPA;
D O I：
10.2165/80-000000000-00000
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [21] ADAPTATION OF A COST-UTILITY MODEL OF RASAGILINE IN THE TREATMENT OF PARKINSON'S DISEASE IN CHINA
    Chen, S.
    Chen, H.
    Zhang, B.
    Shang, H.
    Tan, K. H.
    Ma, F.
    Dorey, J.
    Le Lay, A.
    VALUE IN HEALTH, 2018, 21 : S94 - S94
  • [22] Cost effectiveness of raloxifene. An economic evaluation in a UK setting
    Borgstrom, F
    Jonsson, B
    Johnell, O
    Kanis, J
    Oden, A
    Sykes, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S11 - S11
  • [23] Cost-effectiveness of rasagiline compared to other first line treatment options of early Parkinson's disease in the United States
    Farkouh, R.
    Wilson, M.
    Tarrants, M.
    Castelli-Haley, J.
    Armand, C.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S135 - S135
  • [24] COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES
    Farkouh, R.
    Wilson, M. R.
    Tarrants, M. L.
    Castelli-Haley, J.
    Armand, C.
    VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
  • [25] Cost effectiveness of Apomorphine infusion in the treatment of advanced Parkinson's disease in the UK
    Walter, E.
    Mercsanits, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 287 - 287
  • [26] COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES
    Farkouh, R.
    Wilson, M. R.
    Tarrants, M. L.
    Castelli-Haley, J.
    Armand, C.
    VALUE IN HEALTH, 2009, 12 (03) : A192 - A192
  • [27] Cost-effectiveness of rasagiline versus ropinirole extended release in delaying levodopa in the treatment of early Parkinson's disease in the United States
    Farkouh, R.
    Wilson, M. R.
    Tarrants, M. L.
    Castelli-Haley, J.
    Armand, C.
    MOVEMENT DISORDERS, 2009, 24 : S376 - S377
  • [28] The effectiveness of pramipexole in early and advanced Parkinson's disease and comparison of the results with ropinirole
    Karakaya, F.
    Ozturk, S.
    Ceviz, I.
    Kusbeci, O. Yilmaz
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 668 - 668
  • [29] Broadening the prospects for Parkinson's disease patients with early rasagiline treatment
    Rascol, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 658 - 658
  • [30] Indirect Comparisons of Adverse Events and Dropout Rates in Early Parkinson's Disease Trials of Pramipexole, Ropinirole, and Rasagiline
    Zagmutt, Francisco J.
    Tarrants, Marcy L.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2012, 122 (07) : 345 - 353
12345